Page 70 - ARNM-2-4
P. 70

Advances in Radiotherapy
            & Nuclear Medicine                                             Different approaches for the computation of BED



            43.  Guerrero M, Li XA.  Extending the  linear-quadratic   47.  Ruggieri R, Stavrev P, Naccarato S, Stavreva N, Alongi F,
               model for large fraction doses pertinent to stereotactic   Nahum AE. Optimal dose and fraction number in SBRT
               radiotherapy. Phys Med Biol. 2004;49(20):4825-4835.  of  lung  tumours: A  radiobiological analysis.  Phys Med.
                                                                  2017;44:188-195.
               doi: 10.1088/0031-9155/49/20/012
                                                                  doi: 10.1016/j.ejmp.2016.12.012
            44.  Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic
               model is inappropriate to model high dose per fraction effects   48.  Armpilia CI, Dale RG, Jones B. Determination of the
               in radiosurgery. Semin Radiat Oncol. 2008;18(4):240-243.  optimum  dose per fraction  in fractionated radiotherapy
                                                                  when there is delayed onset of tumour repopulation during
               doi: 10.1016/j.semradonc.2008.04.005
                                                                  treatment. Br J Radiol. 2004;77(921):765-767.
            45.  Astrahan M. Some implications of linear-quadratic-linear
               radiation dose-response with regard to hypofractionation.      doi: 10.1259/bjr/47388747
               Med Phys. 2008;35(9):4161-4172.                 49.  Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell  R,
                                                                  Fowler J. A new approach to dose escalation in non-small-cell
               doi: 10.1118/1.2969065
                                                                  lung cancer. Int J Radiat Oncol Biol Phys. 2001;49(1):23-33.
            46.  Park C, Papiez L, Zhang S, Story M, Timmerman  RD.
               Universal survival curve and single fraction equivalent      doi: 10.1016/S0360-3016(00)01374-2
               dose: Useful tools in understanding potency of   50.  Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology
               ablative radiotherapy.  Int J Radiat Oncol Biol Phys.   of SRS and SBRT: Are more than the 5 Rs involved? Int J
               2008;70(3):847-852.                                Radiat Oncol Biol Phys. 2014;88(2):254-262.
               doi: 10.1016/j.ijrobp.2007.10.059                  doi: 10.1016/j.ijrobp.2013.07.022




















































            Volume 2 Issue 4 (2024)                         10                             doi: 10.36922/arnm.4826
   65   66   67   68   69   70   71   72   73   74   75